Efficacy and Safety of Risankizumab in Patients with Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- DOI
- 10.1007/s40744-024-00638-5
- Published
- 2024 Apr
- Container
- Rheumatology and therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40744-024-00638-5,
title = {Efficacy and Safety of Risankizumab in Patients with Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.},
author = {Su QY and Zhou HN and Xia GM and Zhang RY and Tian HY and Su C and Liu YX and Zhang HY and Cheng T and Huo YH and Li Q and Zhang SX},
year = {2024},
journal = {Rheumatology and therapy},
doi = {10.1007/s40744-024-00638-5},
url = {https://doi.org/10.1007/s40744-024-00638-5}
}RIS
TY - JOUR TI - Efficacy and Safety of Risankizumab in Patients with Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. AU - Su QY AU - Zhou HN AU - Xia GM AU - Zhang RY AU - Tian HY AU - Su C AU - Liu YX AU - Zhang HY AU - Cheng T AU - Huo YH AU - Li Q AU - Zhang SX PY - 2024 JO - Rheumatology and therapy DO - 10.1007/s40744-024-00638-5 UR - https://doi.org/10.1007/s40744-024-00638-5 ER -
APA
QY, S., HN, Z., GM, X., RY, Z., HY, T., C, S., YX, L., HY, Z., T, C., YH, H., Q, L., & SX, Z. (2024). Efficacy and Safety of Risankizumab in Patients with Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Rheumatology and therapy. https://doi.org/10.1007/s40744-024-00638-5
Source records
- pubmed · retrieved 2026-09-26T23:30:21.930Z